|
V. V. Fomin
|
|
|
Anciferov M.B.
Type 2 Diabetes Mellitus: Potentials For Achievement Of Optimal Control Without Side Effects
|
10-16 |
|
Birukova E.V.
How To Achieve Effective Glycemic Control And Reduce The Risk Of Vascular Complications Due To Using Sulfonylurea Medications
|
18-23 |
|
Fomin V.V., Pulin A.A., Saginova E.A.
Diabetic Nephropathy: Does Angiotensin-converting Enzyme Inhibitors Maintain Priority Position?
|
24-29 |
|
Anciferov M.B., Koteshkova O.M., Kleimenova S.A.
Initiation Of Therapy With Insulin Pump In Patients With Type 1 Diabetes
|
30-37 |
|
Petunina N.A., Truhina L.V.
Combined Therapy Of Type 2 Diabetes Mellitus
|
38-41 |
|
Shishkova V.N.
Current Approaches To Therapy Type 2 Diabetes – Effect On Insulin Resistance
|
42-49 |
|
Anciferov M.B.
Clinical Aspects For Use Of Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Benefits For Different Groups Of Patients
|
50-55 |
|
Begma A.N., Begma I.V.
Pathogenetic Aspects Of Treatment Of Distal Peripheral Polyneuropathy In Patients With Diabetes Mellitus
|
56-59 |
|
Anciferov M.B., Markina N.V.
Central Diabetes Insipidus: Modern Concepts And Therapeutic Approaches
|
60-64 |
|
Glinkina I.V., Romancova T.I.
Results Of Observational Program On Use Of Insulin Glargine (lantus®) In Combination With Oral Hypoglycemic Agents For The Treatment Of Type 2 Diabetes Mellitus In Routine Clinical Practice
|
65-68 |
|
Demidova I.U., Makova A.G.
Intensive Insulin Therapy In Acute Cerebrovascular Accident
|
69-71 |
Русский
